.jpg?#)
Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD
Decades ago, Amber Salzman remembers feeling like there was nothing she could do to help her cousin-in-law with a progressive muscle disease called facioscapulohumeral muscular dystrophy, or FSHD. She was a pharmaceutical executive who had ...
Decades ago, Amber Salzman remembers feeling like there was nothing she could do to help her cousin-in-law with a progressive muscle disease called facioscapulohumeral muscular dystrophy, or FSHD.
She was a pharmaceutical executive who had ...
